Zelira Therapeutics Secures US FDA Guidance for Autism Spectrum Therapy; Shares Jump 7%
Zelira Therapeutics Secures US FDA Guidance for Autism Spectrum Therapy; Shares Jump 7%
蕾拉制药公司获得美国FDA关于自闭症谱系障碍疗法的指导意见；股票上涨7%
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间